China SXT Pharmaceuticals Inc
NASDAQ:SXTC
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Price:
2.32
USD
12.08%
Market Closed
Market Cap:
$2.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
|
CN |
|
S
|
Skin N Skin Co Ltd
KOSDAQ:159910
|
KR |
|
W
|
Wielton SA
WSE:WLT
|
PL |
|
Alltek Technology Corp
TWSE:3209
|
TW |
|
C
|
CPI SA
ATHEX:CPI
|
GR |
|
Shin Foong Specialty and Applied Materials Co Ltd
TWSE:6582
|
TW |
|
Manitou BF SA
PAR:MTU
|
FR |
|
Arcosa Inc
NYSE:ACA
|
US |
|
S
|
SAL Saudi Logistics Services Company SJSC
SAU:4263
|
SA |
|
T
|
Tarc Ltd
NSE:TARC
|
IN |
|
Hanmi Science Co Ltd
KRX:008930
|
KR |
|
Af Gruppen ASA
OTC:AGRUF
|
NO |
|
P
|
Pil Italica Lifestyle Ltd
NSE:PILITA
|
IN |
|
H
|
Hexindo Adiperkasa Tbk PT
IDX:HEXA
|
ID |
|
Great Eastern Holdings Ltd
OTC:GEHDF
|
SG |
|
Y
|
Ya Horng Electronic Co Ltd
TWSE:6201
|
TW |
|
Orient Ceratech Ltd
NSE:ORIENTCER
|
IN |
|
VEON Ltd
NASDAQ:VEON
|
NL |
|
Synectics PLC
LSE:SNX
|
UK |
|
Sunopta Inc
F:ZSK
|
US |
|
S
|
ScreenPro Security Inc
CNSX:SCRN
|
CA |
|
B
|
Belluscura PLC
LSE:BELL
|
UK |
|
T
|
Topkey Corp
TWSE:4536
|
TW |
|
Amerigo Resources Ltd
TSX:ARG
|
CA |
Balance Sheet
Balance Sheet Decomposition
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals Inc
Balance Sheet
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals Inc
Currency: USD
| Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
9
|
7
|
13
|
16
|
17
|
12
|
18
|
|
| Cash Equivalents |
0
|
0
|
1
|
9
|
7
|
13
|
16
|
17
|
12
|
18
|
|
| Total Receivables |
4
|
4
|
3
|
4
|
10
|
7
|
6
|
1
|
1
|
2
|
|
| Accounts Receivables |
2
|
3
|
3
|
4
|
4
|
5
|
3
|
1
|
1
|
1
|
|
| Other Receivables |
2
|
1
|
1
|
0
|
6
|
2
|
2
|
0
|
1
|
1
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
0
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
6
|
5
|
6
|
16
|
20
|
23
|
22
|
20
|
14
|
21
|
|
| PP&E Net |
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
8
|
0
|
|
| Total Assets |
6
N/A
|
5
-13%
|
8
+41%
|
17
+128%
|
22
+24%
|
35
+59%
|
34
-3%
|
30
-12%
|
23
-22%
|
22
-6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
7
|
0
|
2
|
3
|
2
|
0
|
|
| Other Current Liabilities |
2
|
2
|
1
|
4
|
3
|
16
|
13
|
9
|
4
|
3
|
|
| Total Current Liabilities |
5
|
4
|
4
|
6
|
12
|
19
|
17
|
15
|
9
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
4
-34%
|
4
+22%
|
6
+46%
|
12
+93%
|
19
+51%
|
17
-8%
|
15
-13%
|
9
-38%
|
6
-32%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
45
|
|
| Retained Earnings |
1
|
0
|
2
|
3
|
7
|
10
|
16
|
22
|
25
|
28
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
8
|
17
|
25
|
31
|
36
|
35
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
|
| Total Equity |
1
N/A
|
2
+150%
|
3
+78%
|
11
+238%
|
9
-15%
|
16
+70%
|
16
+3%
|
15
-11%
|
14
-5%
|
15
+11%
|
|
| Total Liabilities & Equity |
6
N/A
|
5
-13%
|
8
+41%
|
17
+128%
|
22
+24%
|
35
+59%
|
34
-3%
|
30
-12%
|
23
-22%
|
22
-6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
